Summary of Study ST004200
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002649. The data can be accessed directly via it's Project DOI: 10.21228/M87P0Z This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST004200 |
| Study Title | untargeted metabolomics in serum of microplastics exposed mice - Untargeted LC/MS |
| Study Type | in vivo |
| Study Summary | To investigate the impact of ingested MPs on the gut microbiome and the metabolome, 8-week-old male and female C57/BL6 mice were orally gavaged mixed plastic (5 µm) exposure consisting of polystyrene, polyethylene, and the biodegradable/biocompatible plastic, poly(lactic-co-glycolic acid), twice a week for 4 weeks at 0, 2, or 4 mg/week (n = 8/group). Fecal pellets were collected for bacterial DNA extraction and metagenomic shotgun sequencing, and serum was subjected to targeted and untargeted metabolomics. A total of 1162 bacterial species and 1205 metabolites were evaluated for downstream analysis. |
| Institute | University of Washington |
| Department | Environmental and Occupational Health Science |
| Laboratory | Cui Lab |
| Last Name | Kim |
| First Name | Kyle |
| Address | 3150 Stephanie Loop Northeast |
| kk1109@uw.edu | |
| Phone | 3606883268 |
| Submit Date | 2025-09-08 |
| Num Groups | 6 |
| Total Subjects | 24 |
| Num Males | 12 |
| Num Females | 12 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | mzML, raw(Thermo) |
| Analysis Type Detail | LC-MS |
| Release Date | 2025-10-10 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
| Project ID: | PR002649 |
| Project DOI: | doi: 10.21228/M87P0Z |
| Project Title: | In vivo exposure of mixed microplastic particles in mice and its impacts on the murine gut microbiome and metabolome |
| Project Type: | MS quantitative analysis |
| Project Summary: | Microplastics (MPs) are emerging environmental contaminants due to increasing global plastic production and waste. Microplastics, defined as plastic particles less than 5 mm in diameter, are formed through degradation of larger plastics via sunlight, weathering, and microbes. These plastic compounds are widely detected in water, soil, food, as well as human stool and blood. The gut microbiome, often referred to as our second genome, is important in human health and is the primary point of contact for orally ingested microplastics. To investigate the impact of ingested MPs on the gut microbiome and the metabolome, 8-week-old male and female C57/BL6 mice were orally gavaged mixed plastic (5 µm) exposure consisting of polystyrene, polyethylene, and the biodegradable/biocompatible plastic, poly(lactic-co-glycolic acid), twice a week for 4 weeks at 0, 2, or 4 mg/week (n = 8/group). Fecal pellets were collected for bacterial DNA extraction and metagenomic shotgun sequencing, and serum was subjected to targeted and untargeted metabolomics. A total of 1162 bacterial species and 1205 metabolites were evaluated for downstream analysis. MPs exposure resulted in significant sex-specific and dose-dependent changes to the gut microbiome composition along with substantial regulation of predicted metabolic pathways. Untargeted metabolomics in serum showed that a low MPs dose displayed a more prominent effect on key metabolic pathways such as amino acid metabolism, mitochondrial function, and inflammation. Additionally, SCFA-targeted metabolomics showed significant changes in neuroprotective SCFAs levels in both sexes. Our study demonstrates that microplastics dysregulate the gut microbiome and serum metabolome, highlighting potential human disease risks. |
| Institute: | University of Washington |
| Department: | Environmental and Occupational Health Science |
| Laboratory: | Cui Lab |
| Last Name: | Kim |
| First Name: | Kyle |
| Address: | 3150 Stephanie Loop Northeast, Lacey, Washington, 98516, USA |
| Email: | kk1109@uw.edu |
| Phone: | 3606883268 |
| Funding Source: | National Institute of Health (NIH), National Institute of Environmental Health Sciences (NIEHS) |
Subject:
| Subject ID: | SU004352 |
| Subject Type: | Mammal |
| Subject Species: | Mus musculus |
| Taxonomy ID: | 10090 |
| Age Or Age Range: | 8-12 weeks |
| Gender: | Male and female |
| Animal Animal Supplier: | Taconic Biosciences |
| Animal Housing: | Temperature (20–24°C) and humidity (30%–60%) |
| Animal Light Cycle: | 12-h light/dark cycle |
| Animal Feed: | ad libitum |
| Animal Water: | ad libitum |
| Species Group: | C57BL/6 |
Factors:
Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)
| mb_sample_id | local_sample_id | Sample source | Sex | Treatment |
|---|---|---|---|---|
| SA484354 | FCTRL4 | Serum | Female | Control |
| SA484355 | FCTRL3 | Serum | Female | Control |
| SA484356 | FCTRL2 | Serum | Female | Control |
| SA484357 | FCTRL1 | Serum | Female | Control |
| SA484358 | FHIGH3 | Serum | Female | High_MPs |
| SA484359 | FHIGH4 | Serum | Female | High_MPs |
| SA484360 | FHIGH1 | Serum | Female | High_MPs |
| SA484361 | FHIGH2 | Serum | Female | High_MPs |
| SA484362 | FLOW2 | Serum | Female | Low_MPs |
| SA484363 | FLOW1 | Serum | Female | Low_MPs |
| SA484364 | FLOW3 | Serum | Female | Low_MPs |
| SA484365 | FLOW4 | Serum | Female | Low_MPs |
| SA484366 | MCTRL2 | Serum | Male | Control |
| SA484367 | MCTRL4 | Serum | Male | Control |
| SA484368 | MCTRL3 | Serum | Male | Control |
| SA484369 | MCTRL1 | Serum | Male | Control |
| SA484370 | MHIGH1 | Serum | Male | High_MPs |
| SA484371 | MHIGH4 | Serum | Male | High_MPs |
| SA484372 | MHIGH3 | Serum | Male | High_MPs |
| SA484373 | MHIGH2 | Serum | Male | High_MPs |
| SA484374 | MLOW1 | Serum | Male | Low_MPs |
| SA484375 | MLOW2 | Serum | Male | Low_MPs |
| SA484376 | MLOW3 | Serum | Male | Low_MPs |
| SA484377 | MLOW4 | Serum | Male | Low_MPs |
| SA484378 | blank_1 | Serum | NA | Blank |
| SA484379 | blank_2 | Serum | NA | Blank |
| SA484380 | Serum_QC_1 | Serum | NA | QC |
| SA484381 | Serum_QC_2 | Serum | NA | QC |
| SA484382 | Serum_QC_3 | Serum | NA | QC |
| SA484383 | Serum_QC_4 | Serum | NA | QC |
| Showing results 1 to 30 of 30 |
Collection:
| Collection ID: | CO004345 |
| Collection Summary: | Blood was collected via cardiac puncture and samples were spun and separated for serum. Frozen serum samples were first thawed overnight under 4oC, and 50 μL of each sample was placed in a 2 mL Eppendorf vial prior to metabolomic analysis |
| Sample Type: | Blood (serum) |
Treatment:
| Treatment ID: | TR004361 |
| Treatment Summary: | 8-week-old male and female C57/BL6 mice were orally gavaged mixed plastic (5 µm) exposure consisting of polystyrene, polyethylene, and the biodegradable/biocompatible plastic, poly(lactic-co-glycolic acid), twice a week for 4 weeks at 0, 2, or 4 mg/week (n = 8/group). |
| Treatment: | in vivo oral ingestion |
| Treatment Compound: | mixed microplastics (polystyrene, polyethylene, poly lactic-co glycolic acid) |
| Treatment Route: | gastric oral gavage |
| Treatment Dose: | 0mg/wk, 2mg/wk, 4mg/wk |
| Treatment Dosevolume: | 100 ul of 10mg/ml twice a week for 2mg/wk and 200ul of 10mg/ml twice a week for 4mg/wk |
| Treatment Doseduration: | 4 weeks |
| Treatment Vehicle: | water |
Sample Preparation:
| Sampleprep ID: | SP004358 |
| Sampleprep Summary: | Frozen serum samples were first thawed overnight under 4oC, and 50 μL of each sample was placed in a 2 mL Eppendorf vial. The initial step for protein precipitation and metabolite extraction was performed by adding 500 μL MeOH and 50 μL internal standard solution (containing 1,810.5 μM 13C3-lactate and 142 μM 13C5-glutamic acid). The mixture was then vortexed for 10 s and stored at -20oC for 30 min, followed by centrifugation at 14,000 RPM for 10 min at 4° C. The supernatants (450 μL) were collected into a new Eppendorf vial and dried using a CentriVap Concentrator (Labconco, Fort Scott, KS). The dried samples were reconstituted in 150 μL of 40% PBS/60% ACN. A pooled sample, which was a mixture of all plasma samples was used as the quality-control (QC) sample. Briefly, all LC-MS experiments were performed on a Thermo Vanquish UPLC-Exploris 240 Orbitrap MS instrument (Waltham, MA). Each sample was injected twice, 10 µL for analysis using negative ionization mode and 4 µL for analysis using positive ionization mode. Both chromatographic separations were performed in hydrophilic interaction chromatography (HILIC) mode on a Waters XBridge BEH Amide column (150 x 2.1 mm, 2.5 µm particle size, Waters Corporation, Milford, MA). The flow rate was 0.3 mL/min, the auto-sampler temperature was kept at 4 ̊C, and the column compartment was set at 40 ̊C. The mobile phase was composed of Solvents A (10 mM ammonium acetate, 10 mM ammonium hydroxide in 95% H2O/5% ACN) and B (10 mM ammonium acetate, 10 mM ammonium hydroxide in 95% ACN/5% H2O). After the initial 1 min isocratic elution of 90% B, the percentage of Solvent B decreased to 40% at t=11 min. The composition of Solvent B maintained at 40% for 4 min (t=15 min), and then the percentage of B gradually went back to 90%, to prepare for the next injection. Using a mass spectrometer equipped with an electrospray ionization (ESI) source, we will collect untargeted data from 70 to 1050 m/z. |
Chromatography:
| Chromatography ID: | CH005303 |
| Chromatography Summary: | The untargeted LC-MS metabolomics method used here was modeled after that developed and used in a growing number of studies (Gu et al. 2015; Wei et al. 2021; Jin et al. 2023; Mohr et al. 2024; Scieszka et al. 2023; Kim et al. 2023; Garcia et al. 2024). Briefly, all LC-MS experiments were performed on a Thermo Vanquish UPLC-Exploris 240 Orbitrap MS instrument (Waltham, MA). Each sample was injected twice, 10 µL for analysis using negative ionization mode and 4 µL for analysis using positive ionization mode. Both chromatographic separations were performed in hydrophilic interaction chromatography (HILIC) mode on a Waters XBridge BEH Amide column (150 x 2.1 mm, 2.5 µm particle size, Waters Corporation, Milford, MA). The flow rate was 0.3 mL/min, the auto-sampler temperature was kept at 4 ̊C, and the column compartment was set at 40 ̊C. The mobile phase was composed of Solvents A (10 mM ammonium acetate, 10 mM ammonium hydroxide in 95% H2O/5% ACN) and B (10 mM ammonium acetate, 10 mM ammonium hydroxide in 95% ACN/5% H2O). After the initial 1 min isocratic elution of 90% B, the percentage of Solvent B decreased to 40% at t=11 min. The composition of Solvent B maintained at 40% for 4 min (t=15 min), and then the percentage of B gradually went back to 90%, to prepare for the next injection. Using a mass spectrometer equipped with an electrospray ionization (ESI) source, we will collect untargeted data from 70 to 1050 m/z. |
| Instrument Name: | Thermo Vanquish |
| Column Name: | XBridge BEH Amide (150 x 2.1 mm, 2.5 um) |
| Column Temperature: | 40 ̊C |
| Flow Gradient: | After the initial 1 min isocratic elution of 90% B, the percentage of Solvent B decreased to 40% at t=11 min. The composition of Solvent B maintained at 40% for 4 min (t=15 min), and then the percentage of B gradually went back to 90%, to prepare for the next injection |
| Flow Rate: | 0.3 mL/min |
| Solvent A: | 95% water/5% acetonitrile; 10 mM ammonium acetate; 10 mM ammonium hydroxide |
| Solvent B: | 95% acetonitrile/5% water; 10 mM ammonium acetate; 10 mM ammonium hydroxide |
| Chromatography Type: | HILIC |
Analysis:
| Analysis ID: | AN006985 |
| Analysis Type: | MS |
| Chromatography ID: | CH005303 |
| Num Factors: | 8 |
| Num Metabolites: | 1437 |
| Units: | Relative abundance |
| Analysis ID: | AN006986 |
| Analysis Type: | MS |
| Chromatography ID: | CH005303 |
| Num Factors: | 8 |
| Num Metabolites: | 1437 |
| Units: | Relative abundance |